2 days Green stocks on red days Reddit

   X     

4 days Amgen, Inc. (AMGN) Citi’s 2025 Virtual Oncology Leadership Summit Conference (Transcript) Seeking Alpha

   X     

4 days Market Update: AMGN, KO, KR, KSS, ANET Yahoo Finance

   X     

2 weeks Amgen, Inc. (AMGN) Oppenheimer 35th Annual Healthcare Life Sciences Conference Call Transcript Seeking Alpha

   X     

2 weeks Amgen: Multiple Strengths, But The Valuation Is A Concern Seeking Alpha

   X     

2 weeks Amgen Stock Has Surged. Here’s Where It’s Headed Next. Yahoo Finance

   X     

2 weeks Amgen Q4 Earnings: Good Quarter, Ok Guidance, But MariTide Concerns Me (Rating Downgrade) Seeking Alpha

   X     

3 weeks Amgen Q4 Earnings: Strong Pipeline And Label Expansions Justify Buy Rating Seeking Alpha

   X     

3 weeks Biotech Stock Roundup: REGN Up on Q4 Results, VRTX, AXSM Gain on Drug Approval Zacks

   X     

3 weeks AMGN’s Q4 Earnings Beat, Obesity Candidate Under FDA Clinical Hold Zacks

   X     

3 weeks Amgen stock slips on annual outlook; Q4 results top estimates Investing.com

   X     

3 weeks Amgen Inc. 2024 Q4 – Results – Earnings Call Presentation Seeking Alpha

   X     

3 weeks Amgen, Inc. (AMGN) Q4 2024 Earnings Call Transcript Seeking Alpha

   X     

3 weeks Compared to Estimates, Amgen (AMGN) Q4 Earnings: A Look at Key Metrics Zacks

   X     

3 weeks Amgen Discloses FDA Paused Study of Early-Stage Obesity Drug Yahoo Finance

   X     

3 weeks Amgen profit beats estimates, next MariTide studies start by mid-year Investing.com

   X     

3 weeks Amgen (AMGN) Q4 Earnings and Revenues Surpass Estimates Zacks

   X     

3 weeks Amgen Shrugs Off A Surprise Setback For One Of Its Obesity Drugs Investor's Business Daily

   X     

3 weeks Amgen shares sink despite quarterly beat, FDA places obesity drug on clinical hold YouTube

   X     

3 weeks Amgen earnings beat by $0.27, revenue topped estimates Investing.com

   X     

3 weeks Amgen profits rise, next MariTide studies start by mid-year Yahoo Finance

   X     

3 weeks Amgen stock falls as profit outlook disappoints investors Investing.com

   X     

3 weeks The Zacks Analyst Blog Highlights Merck, Pfizer, Eli Lilly, Amgen and Bristol Myers Squibb Zacks

   X     

3 weeks Electronic Arts, Amgen, Google lead earnings reports Tuesday Investing.com

   X     

3 weeks The Zacks Analyst Blog Highlights Amgen, Cencora, Humana and Ardent Health Zacks

   X     

3 weeks Curious about Amgen (AMGN) Q4 Performance? Explore Wall Street Estimates for Key Metrics Zacks

   X     

3 weeks Here’s Why Amgen (AMGN) is a Strong Momentum Stock Zacks

   X     

4 weeks Amgen Set to Report Q4 Earnings: Is a Beat in the Cards? Zacks

   X     

4 weeks Amgen (AMGN) Stock Dips While Market Gains: Key Facts Zacks

   X     

4 weeks Amgen (AMGN) Reports Next Week: Wall Street Expects Earnings Growth Zacks

   X     

4 weeks Is Most-Watched Stock Amgen Inc. (AMGN) Worth Betting on Now? Zacks

   X     

1 month Amgen (AMGN) Surpasses Market Returns: Some Facts Worth Knowing Zacks

   X     

1 month Amgen: Likely To Be Rangebound (Rating Downgrade) Seeking Alpha

   X     

1 month Amgen’s Lumakras Gets FDA Nod for Expanded Use in Colorectal Cancer Zacks

   X     

1 month Amgen (AMGN) Rises Yet Lags Behind Market: Some Facts Worth Knowing Zacks

   X     

1 month Amgen (AMGN) Stock Falls Amid Market Uptick: What Investors Need to Know Zacks

   X     

1 month Why Amgen (AMGN) is a Top Momentum Stock for the Long-Term Zacks

   X     

1 month Amgen Inc. (AMGN) 43rd Annual J.P. Morgan Healthcare Conference 2025 (Transcript) Seeking Alpha

   X     

1 month Why Amgen (AMGN) is a Top Value Stock for the Long-Term Zacks

   X     

2 months Top Analyst Reports for Microsoft, Exxon Mobil & Amgen Zacks

   X     

2 months Will Amgen (AMGN) Beat Estimates Again in Its Next Earnings Report? Zacks

   X     

2 months Amgen: The Buying Opportunity Has Now Arrived (Rating Upgrade) Seeking Alpha

   X     

2 months Amgen: Growth Potential Met By High Debt Levels Seeking Alpha

   X     

2 months Amgen: Blockbusters, Emerging Therapies, And Investment Potential Seeking Alpha

   X     

2 months Amgen: Strong Fundamentals But Expensive Valuation Justifies A Hold Seeking Alpha

   X     

2 months Amgen (AMGN) Advances While Market Declines: Some Information for Investors Zacks

   X     

2 months Amgen (AMGN) Suffers a Larger Drop Than the General Market: Key Insights Zacks

   X     

2 months Here’s Why Amgen (AMGN) Gained But Lagged the Market Today Zacks

   X     

2 months Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know Zacks

   X     

2 months Amgen stock gains on Novo Nordisk’s weightloss drug blunder FXStreet

   X